securities fraud

Corcept Therapeutics faces securities lawsuit alleging it misrepresented relacorilant's FDA approval prospects, causing stock to plunge 50% after regulatory rejection.

BellRing Brands faces class action lawsuit alleging it misrepresented sales performance by failing to disclose that revenue growth was driven by customer inventory buildup rather than organic demand.

AMC faces class action lawsuit alleging it misled investors about Preferred Equity Unit rights, excluding APE holders from a 2023 dividend distribution through undisclosed technical loopholes.

Lakeland Industries faces class action lawsuit alleging executives made false statements about business performance, concealing shipping delays, production issues, and tariffs affecting Pacific Helmets and Jolly segments.

Ardent Health faces class action lawsuit for overstating Q3 2025 revenue and EBITDA guidance by $57.5 million due to inadequate accounting assessments and cost pressures.

Fermi Inc. faces securities class action over alleged false statements regarding Project Matador campus development and undisclosed single-tenant dependency risks.

Four companies face securities fraud class action lawsuits for allegedly making false statements. Investors have until late March 2026 to nominate lead plaintiffs.

Richtech Robotics faces class action lawsuit for allegedly misrepresenting Microsoft partnership. Stock fell 20.9% after Microsoft clarified the relationship wasn't a commercial partnership.

Class action lawsuit filed against China Liberal Education for alleged pump-and-dump scheme. Shareholders who bought stock January 2025-2026 can seek recovery; lead plaintiff deadline is March 31, 2026.

uniQure faces securities fraud lawsuit after FDA rejected its drug candidate AMT-130, causing a 49% stock plunge. Plaintiffs allege the company failed to disclose material information to investors.

Corcept Therapeutics faces securities fraud lawsuit for failing to disclose FDA setback on relacorilant drug, causing 50% stock decline.

Law firm files securities fraud lawsuit against BellRing after 52% stock plunge, alleging failure to disclose inventory and supply chain issues.

Class action lawsuit filed against Navan for allegedly omitting material information about surging marketing costs in October 2025 IPO documents.

Securities class action filed against Enphase Energy for allegedly misleading statements on inventory and tax credits. Claim deadline April 2026.

Rosen Law Firm investigates Phoenix Education Partners for allegedly failing to disclose a major data breach affecting 3.5 million individuals to investors timely.

Law firm Johnson Fistel launches securities investigation into Claritev after 45% stock decline following disappointing 2025 financial results disclosure.

Law firm investigates Camping World for potential securities violations after missing earnings expectations and suspending dividends. Shareholders encouraged to participate.

Ardent Health faces class action lawsuit over inflated receivables and delayed loss recognition. Stock dropped 34% after $43M revenue restatement; investors have until March 9 to join.

NuScale Power faces securities lawsuit for allegedly failing to disclose material risks tied to its ENTRA1 partnership, which resulted in a $495 million payment obligation and significant stock decline.

Apollo Global Management faces legal investigation over undisclosed Jeffrey Epstein business relationship, contradicting prior public statements and raising investor disclosure concerns.